Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endarterectomy, Carotid | 32 | 2022 | 110 | 4.650 |
Why?
|
| Carotid Stenosis | 32 | 2022 | 163 | 4.620 |
Why?
|
| Stents | 33 | 2022 | 657 | 2.850 |
Why?
|
| Stroke | 42 | 2023 | 2161 | 2.110 |
Why?
|
| Randomized Controlled Trials as Topic | 8 | 2021 | 929 | 1.020 |
Why?
|
| Carotid Arteries | 6 | 2015 | 110 | 0.900 |
Why?
|
| Myocardial Infarction | 13 | 2021 | 807 | 0.880 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 143 | 0.750 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 154 | 0.750 |
Why?
|
| Patient Selection | 4 | 2020 | 592 | 0.740 |
Why?
|
| Pandemics | 2 | 2020 | 346 | 0.720 |
Why?
|
| Metabolic Syndrome | 4 | 2014 | 191 | 0.700 |
Why?
|
| Angioplasty | 7 | 2018 | 118 | 0.690 |
Why?
|
| Cerebral Revascularization | 7 | 2019 | 45 | 0.680 |
Why?
|
| Life Style | 4 | 2020 | 338 | 0.650 |
Why?
|
| Anemia, Sickle Cell | 6 | 2022 | 364 | 0.640 |
Why?
|
| Hypertension | 7 | 2021 | 1531 | 0.630 |
Why?
|
| Postoperative Complications | 6 | 2017 | 1615 | 0.570 |
Why?
|
| Prosthesis Implantation | 2 | 2018 | 83 | 0.540 |
Why?
|
| Aged | 40 | 2022 | 14842 | 0.520 |
Why?
|
| Risk Factors | 24 | 2022 | 5719 | 0.500 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2015 | 125 | 0.500 |
Why?
|
| Middle Aged | 42 | 2022 | 21119 | 0.470 |
Why?
|
| Treatment Outcome | 26 | 2022 | 7028 | 0.470 |
Why?
|
| Antihypertensive Agents | 4 | 2021 | 497 | 0.440 |
Why?
|
| Diabetes Mellitus | 4 | 2020 | 693 | 0.430 |
Why?
|
| Male | 47 | 2022 | 37281 | 0.420 |
Why?
|
| Humans | 66 | 2023 | 68525 | 0.410 |
Why?
|
| Endovascular Procedures | 4 | 2019 | 366 | 0.410 |
Why?
|
| Skiing | 3 | 2007 | 4 | 0.390 |
Why?
|
| Female | 47 | 2022 | 38015 | 0.380 |
Why?
|
| Blood Pressure | 5 | 2021 | 1447 | 0.380 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2019 | 99 | 0.340 |
Why?
|
| Aged, 80 and over | 14 | 2022 | 4843 | 0.340 |
Why?
|
| Carotid Artery Diseases | 3 | 2015 | 83 | 0.340 |
Why?
|
| Exercise | 1 | 2014 | 657 | 0.330 |
Why?
|
| Heart Diseases | 2 | 2023 | 276 | 0.320 |
Why?
|
| Patient Participation | 2 | 2020 | 145 | 0.310 |
Why?
|
| Credentialing | 3 | 2019 | 23 | 0.300 |
Why?
|
| Risk Assessment | 11 | 2022 | 2004 | 0.270 |
Why?
|
| Incidence | 9 | 2019 | 1582 | 0.270 |
Why?
|
| Follow-Up Studies | 11 | 2019 | 3256 | 0.270 |
Why?
|
| Head Protective Devices | 2 | 2007 | 15 | 0.260 |
Why?
|
| Clinical Competence | 4 | 2019 | 657 | 0.250 |
Why?
|
| Perioperative Care | 2 | 2015 | 100 | 0.250 |
Why?
|
| United States | 16 | 2023 | 7335 | 0.250 |
Why?
|
| Clinical Trials as Topic | 3 | 2022 | 848 | 0.240 |
Why?
|
| Brain Ischemia | 3 | 2019 | 665 | 0.220 |
Why?
|
| Prospective Studies | 12 | 2019 | 3702 | 0.210 |
Why?
|
| Asymptomatic Diseases | 5 | 2021 | 43 | 0.210 |
Why?
|
| Betacoronavirus | 2 | 2020 | 116 | 0.210 |
Why?
|
| Age Factors | 4 | 2019 | 1860 | 0.210 |
Why?
|
| Time Factors | 11 | 2019 | 4655 | 0.200 |
Why?
|
| American Heart Association | 2 | 2023 | 142 | 0.200 |
Why?
|
| Guideline Adherence | 2 | 2021 | 284 | 0.200 |
Why?
|
| Biomarkers | 6 | 2018 | 1593 | 0.200 |
Why?
|
| Erythrocyte Transfusion | 3 | 2019 | 72 | 0.190 |
Why?
|
| Cognitive Dysfunction | 2 | 2021 | 176 | 0.190 |
Why?
|
| Multicenter Studies as Topic | 2 | 2019 | 186 | 0.190 |
Why?
|
| Socioeconomic Factors | 3 | 2020 | 955 | 0.190 |
Why?
|
| Cardiovascular Diseases | 2 | 2023 | 938 | 0.180 |
Why?
|
| Smoking Prevention | 2 | 2014 | 259 | 0.180 |
Why?
|
| Logistic Models | 8 | 2016 | 1419 | 0.180 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 84 | 0.180 |
Why?
|
| Research Design | 3 | 2020 | 729 | 0.180 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2021 | 503 | 0.180 |
Why?
|
| Risk | 6 | 2017 | 563 | 0.170 |
Why?
|
| Radiography, Interventional | 1 | 2019 | 49 | 0.170 |
Why?
|
| Prevalence | 5 | 2019 | 1609 | 0.170 |
Why?
|
| Smoking | 3 | 2020 | 1449 | 0.170 |
Why?
|
| Endpoint Determination | 1 | 2018 | 82 | 0.160 |
Why?
|
| Dyslipidemias | 2 | 2020 | 98 | 0.160 |
Why?
|
| Cranial Nerve Injuries | 2 | 2015 | 4 | 0.160 |
Why?
|
| Sex Distribution | 3 | 2009 | 272 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2020 | 326 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 772 | 0.140 |
Why?
|
| Anesthesia, Conduction | 1 | 2016 | 14 | 0.140 |
Why?
|
| Survival Analysis | 2 | 2018 | 714 | 0.140 |
Why?
|
| Lost to Follow-Up | 1 | 2015 | 7 | 0.130 |
Why?
|
| Anesthesia, General | 1 | 2016 | 86 | 0.130 |
Why?
|
| Age Distribution | 2 | 2008 | 319 | 0.130 |
Why?
|
| Thrombin | 1 | 2015 | 117 | 0.130 |
Why?
|
| Cerebral Angiography | 1 | 2015 | 151 | 0.130 |
Why?
|
| Blood Coagulation | 1 | 2015 | 123 | 0.130 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 129 | 0.130 |
Why?
|
| North America | 3 | 2021 | 111 | 0.130 |
Why?
|
| Data Interpretation, Statistical | 2 | 2018 | 329 | 0.130 |
Why?
|
| Judgment | 1 | 2014 | 40 | 0.120 |
Why?
|
| Geography | 2 | 2019 | 80 | 0.120 |
Why?
|
| Hypolipidemic Agents | 1 | 2014 | 82 | 0.120 |
Why?
|
| Emergency Treatment | 1 | 2014 | 52 | 0.120 |
Why?
|
| Comorbidity | 3 | 2020 | 1425 | 0.120 |
Why?
|
| Blood Transfusion | 1 | 2015 | 205 | 0.120 |
Why?
|
| Choice Behavior | 1 | 2014 | 85 | 0.120 |
Why?
|
| Heart Valve Diseases | 1 | 2015 | 123 | 0.120 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2013 | 25 | 0.120 |
Why?
|
| Goals | 1 | 2014 | 65 | 0.120 |
Why?
|
| Severity of Illness Index | 5 | 2018 | 1851 | 0.120 |
Why?
|
| Racism | 1 | 2014 | 59 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 180 | 0.120 |
Why?
|
| Models, Statistical | 2 | 2013 | 446 | 0.110 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2014 | 137 | 0.110 |
Why?
|
| Endarterectomy | 1 | 2012 | 22 | 0.110 |
Why?
|
| Patient Dropouts | 1 | 2013 | 98 | 0.110 |
Why?
|
| Bias | 1 | 2013 | 148 | 0.110 |
Why?
|
| Thrombosis | 1 | 2013 | 218 | 0.110 |
Why?
|
| Health Promotion | 2 | 2007 | 407 | 0.110 |
Why?
|
| Sepsis | 1 | 2015 | 233 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2015 | 403 | 0.110 |
Why?
|
| Thrombolytic Therapy | 1 | 2014 | 233 | 0.100 |
Why?
|
| Electrocardiography | 4 | 2018 | 601 | 0.100 |
Why?
|
| Skin Neoplasms | 2 | 2007 | 375 | 0.100 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 361 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 371 | 0.100 |
Why?
|
| Proportional Hazards Models | 4 | 2015 | 791 | 0.100 |
Why?
|
| Diet | 1 | 2015 | 513 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 424 | 0.100 |
Why?
|
| Odds Ratio | 4 | 2016 | 880 | 0.100 |
Why?
|
| Hospitalization | 2 | 2014 | 977 | 0.100 |
Why?
|
| Spain | 2 | 2021 | 34 | 0.100 |
Why?
|
| Physicians | 1 | 2014 | 324 | 0.100 |
Why?
|
| Fibrinolytic Agents | 1 | 2014 | 377 | 0.100 |
Why?
|
| Child | 6 | 2019 | 6400 | 0.090 |
Why?
|
| Radiology, Interventional | 1 | 2010 | 21 | 0.090 |
Why?
|
| Education | 1 | 2010 | 83 | 0.090 |
Why?
|
| Ultraviolet Rays | 2 | 2007 | 130 | 0.090 |
Why?
|
| Sunburn | 2 | 2007 | 6 | 0.090 |
Why?
|
| Demography | 1 | 2010 | 279 | 0.090 |
Why?
|
| Hydroxyurea | 2 | 2019 | 57 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2019 | 536 | 0.090 |
Why?
|
| Attitude | 2 | 2007 | 121 | 0.080 |
Why?
|
| Quality of Life | 2 | 2015 | 1515 | 0.080 |
Why?
|
| Adult | 8 | 2017 | 21375 | 0.080 |
Why?
|
| Adolescent | 6 | 2022 | 8903 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2011 | 248 | 0.080 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 696 | 0.080 |
Why?
|
| Algorithms | 1 | 2013 | 1194 | 0.080 |
Why?
|
| Southeastern United States | 1 | 2008 | 281 | 0.070 |
Why?
|
| Mortality | 1 | 2008 | 162 | 0.070 |
Why?
|
| Tobacco | 1 | 2007 | 161 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2008 | 158 | 0.070 |
Why?
|
| Canada | 2 | 2020 | 266 | 0.070 |
Why?
|
| Health Planning Guidelines | 1 | 2006 | 23 | 0.070 |
Why?
|
| State Government | 1 | 2006 | 34 | 0.070 |
Why?
|
| Policy Making | 1 | 2006 | 51 | 0.070 |
Why?
|
| Indians, North American | 1 | 2006 | 64 | 0.070 |
Why?
|
| Mass Screening | 2 | 2016 | 837 | 0.070 |
Why?
|
| Smoking Cessation | 1 | 2014 | 1032 | 0.070 |
Why?
|
| Health Policy | 1 | 2007 | 221 | 0.070 |
Why?
|
| Recreation | 1 | 2005 | 19 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2019 | 3185 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2019 | 181 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2005 | 68 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2019 | 2356 | 0.060 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2006 | 127 | 0.060 |
Why?
|
| Blood Flow Velocity | 2 | 2016 | 172 | 0.060 |
Why?
|
| Health Education | 1 | 2007 | 279 | 0.060 |
Why?
|
| Occupational Exposure | 1 | 2005 | 122 | 0.060 |
Why?
|
| Environmental Exposure | 1 | 2006 | 269 | 0.060 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 546 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2006 | 402 | 0.060 |
Why?
|
| Mammography | 1 | 2006 | 310 | 0.060 |
Why?
|
| Moyamoya Disease | 1 | 2022 | 7 | 0.060 |
Why?
|
| Educational Status | 1 | 2003 | 273 | 0.060 |
Why?
|
| Colorado | 3 | 2007 | 26 | 0.050 |
Why?
|
| Data Collection | 1 | 2003 | 420 | 0.050 |
Why?
|
| Sex Factors | 2 | 2019 | 1265 | 0.050 |
Why?
|
| Primary Prevention | 1 | 2022 | 115 | 0.050 |
Why?
|
| Drug Utilization | 1 | 2021 | 119 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 1465 | 0.050 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 26 | 0.050 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 95 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2019 | 39 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2021 | 135 | 0.050 |
Why?
|
| Young Adult | 2 | 2022 | 5708 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2020 | 95 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2014 | 631 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 648 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2005 | 766 | 0.040 |
Why?
|
| Infection Control | 1 | 2020 | 101 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 201 | 0.040 |
Why?
|
| Telemedicine | 2 | 2020 | 699 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 248 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2022 | 7264 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2019 | 122 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2018 | 301 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 2077 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 951 | 0.040 |
Why?
|
| Sunscreening Agents | 2 | 2007 | 7 | 0.040 |
Why?
|
| Life Expectancy | 1 | 2016 | 51 | 0.030 |
Why?
|
| Antithrombin III | 1 | 2015 | 23 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2015 | 47 | 0.030 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2015 | 50 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2015 | 82 | 0.030 |
Why?
|
| Blood Pressure Determination | 1 | 2016 | 149 | 0.030 |
Why?
|
| Registries | 1 | 2018 | 730 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 349 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 424 | 0.030 |
Why?
|
| Health Status | 1 | 2018 | 429 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 2264 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2015 | 260 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 85 | 0.030 |
Why?
|
| Remote Consultation | 1 | 2014 | 50 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 572 | 0.030 |
Why?
|
| Awareness | 1 | 2014 | 81 | 0.030 |
Why?
|
| Informed Consent | 1 | 2015 | 127 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 161 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 249 | 0.030 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2013 | 3 | 0.030 |
Why?
|
| Telephone | 1 | 2014 | 160 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 239 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2013 | 168 | 0.030 |
Why?
|
| Feeding Behavior | 1 | 2015 | 224 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2014 | 291 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2015 | 252 | 0.030 |
Why?
|
| Cognition | 1 | 2017 | 512 | 0.030 |
Why?
|
| Learning Curve | 1 | 2012 | 20 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 330 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2012 | 32 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 2093 | 0.030 |
Why?
|
| Models, Economic | 1 | 2012 | 69 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2012 | 105 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2014 | 294 | 0.030 |
Why?
|
| Markov Chains | 1 | 2012 | 133 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2012 | 193 | 0.030 |
Why?
|
| Troponin T | 1 | 2011 | 16 | 0.030 |
Why?
|
| Probability | 1 | 2012 | 244 | 0.030 |
Why?
|
| Obesity, Abdominal | 1 | 2011 | 5 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2011 | 32 | 0.030 |
Why?
|
| Survival Rate | 1 | 2014 | 1055 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2011 | 112 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1139 | 0.020 |
Why?
|
| Recurrence | 1 | 2013 | 948 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 2798 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 503 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2010 | 36 | 0.020 |
Why?
|
| Medicine | 1 | 2010 | 51 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1046 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2012 | 267 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2012 | 346 | 0.020 |
Why?
|
| Health Surveys | 1 | 2011 | 488 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 177 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2010 | 168 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2010 | 358 | 0.020 |
Why?
|
| Local Government | 1 | 2007 | 17 | 0.020 |
Why?
|
| Law Enforcement | 1 | 2007 | 10 | 0.020 |
Why?
|
| Public Opinion | 1 | 2007 | 32 | 0.020 |
Why?
|
| Eye Protective Devices | 1 | 2007 | 4 | 0.020 |
Why?
|
| Child Welfare | 1 | 2007 | 53 | 0.020 |
Why?
|
| Safety | 1 | 2007 | 145 | 0.020 |
Why?
|
| Politics | 1 | 2006 | 31 | 0.020 |
Why?
|
| Protective Clothing | 1 | 2005 | 12 | 0.020 |
Why?
|
| Sunlight | 1 | 2005 | 59 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2007 | 502 | 0.020 |
Why?
|
| Forecasting | 1 | 2006 | 277 | 0.020 |
Why?
|
| Focus Groups | 1 | 2005 | 247 | 0.020 |
Why?
|
| Parents | 1 | 2007 | 309 | 0.020 |
Why?
|
| Program Development | 1 | 2005 | 240 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 2222 | 0.010 |
Why?
|
| Health Behavior | 1 | 2007 | 458 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2006 | 467 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 1533 | 0.010 |
Why?
|